Trial
NCT02768220
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
—
Condition
SGLT-2 Inhibitors
Intervention
empagliflozin
Why stopped
no funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-15